Please login to the form below

Not currently logged in
Email:
Password:

Germany

This page shows the latest Germany news and features for those working in and with pharma, biotech and healthcare.

Bluebird bio launches beta thalassaemia gene therapy Zynteglo in Germany

Bluebird bio launches beta thalassaemia gene therapy Zynteglo in Germany

As it had previously planned, bluebird has entered into an outcomes-based payment agreement with multiple statutory health insurance providers in Germany. ... Now that bluebird has launched Zynteglo is Germany, the UK will be firmly in its sights.

Latest news

More from news
Approximately 44 fully matching, plus 841 partially matching documents found.

Latest Intelligence

  • The 2019 CPhI Pharma Index Report The 2019 CPhI Pharma Index Report

    Union exit and they have seemingly predicted that Germany will be the primary beneficiary of this move. ... In fact, according to Farmaindustria, Italy has equalled Germany in both total production of finished goods and production per unit.

  • Building European biotech firms to rival those of the US Building European biotech firms to rival those of the US

    Germany is European biotech’s sleeping giant. “Germany is Europe’s great untapped player in biotech,” said Richard. ... For a number of reasons, such as taxes and red tape, the sector hasn’t really taken off there as much as it could have until

  • European biotech: a new generation of leaders emerges European biotech: a new generation of leaders emerges

    potential academic researchers across the continent, with a number of specialist venture capital firms and incubators helping to build success stories in the UK, France, Germany, Belgium and Denmark across a ... Morphosys. One of Europe’s star

  • A new EU in the making, what lies ahead for pharma? A new EU in the making, what lies ahead for pharma?

    The HTA file is in a difficult situation at the moment with Germany and France blocking it. ... For smaller companies however, the stakes are higher. If France, Germany and a few other countries want to support innovation and faster market uptake up to

  • Is anybody listening? Is anybody listening?

    Similarly, authorities in Germany, China, Russia and Australia – as well as the EU in general – are all taking measures to clamp down on companies that aren’t doing enough to fulfil

More from intelligence
Approximately 9 fully matching, plus 124 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 74 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 69 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics